Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | TERT | O14746 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2196672 | 0.91 | CHRM2 (0.75) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL9146038 | 0.88 | CHRM2 (0.67) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL9151817 | 0.81 | CHRM2 (0.58) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2364432 | 0.80 | TERT (0.72) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL13073061 | 0.78 | CHRM2 (1.00) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL26378291 | 0.77 | TERT (1.00) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL17265030 | 0.77 | CHRM2 (0.64) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2188395 | 0.76 | CHRM2 (0.69) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| Bromide SCHEMBL3989856 | 0.76 | CHRM2 (1.00) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12802779 | 0.76 | CHRM2 (0.79) | CHRM2MEN1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4493883-A | Electrophotographic toner compositions containing novel imide charge control _additives | XEROX CORPORATION (US) | 1985-01-15 | — | — | US | disclosed |